Feb 15, 2021 | CMT Research Updates, CMTRF Funded Research, Drug Development, Gene Therapy, Research news
In January 2019, the CMT Research Foundation began funding a research project led by Dr. Kleopas Kleopa at the Cyprus Institute of Neurology & Genetics to study a gene therapy approach to lower levels of PMP22 protein, which is the protein coded for by the gene...
Feb 10, 2021 | CMT Research Updates, CMTRF Funded Research, Drug Development, Gene Therapy, Research news
Collaboration with World-Renowned Researcher Dr. James Dahlman Aims to Identify Lipid Nanoparticles for Peripheral Nervous System Delivery Using High-Throughput Screening One of the most significant challenges in Charcot-Marie-Tooth drug development is delivering...
Nov 10, 2020 | CMT Research Updates, CMTRF Funded Research, Drug Development, Gene Therapy, Research news
By: Keith N. Fargo, Ph.D., Chief Scientific Officer, CMT Research Foundation The CMT Research Foundation is currently funding a research project led by AcuraStem aimed at producing effective treatments for CMT2A. Using stem cells derived from adult patients, AcuraStem...
Nov 10, 2020 | CMT Research Updates, CMTRF Funded Research, Drug Development, Gene Therapy, Research news
By: Keith N. Fargo, Ph.D., Chief Scientific Officer, CMT Research Foundation The CMT Research Foundation is currently funding a research project led by Dr. Kleopas Kleopa and his team at the Cyprus Institute of Neurology & Genetics to study a gene therapy approach...
Nov 10, 2020 | CMT Research Updates, CMTRF Funded Research, Drug Development, Gene Therapy, Research news
By: Keith N. Fargo, Ph.D., Chief Scientific Officer, CMT Research Foundation The CMT Research Foundation is currently funding a research project led by DTx Pharma to design genetic therapies for Charcot-Marie-Tooth disease (CMT). By attaching the genetic sequences to...
Oct 14, 2020 | CMT Research Updates, CMTRF Funded Research, Drug Development, Research news
By: Keith Fargo, Chief Scientific Officer, CMT Research Foundation The CMT Research Foundation is pleased to announce a new research program to develop a precision medicine approach for Charcot-Marie-Tooth (CMT) disease. Precision medicine is a medical model that...